Based on typical regulatory timelines and the trial readout schedule, approval is projected for 2027 at the earliest
Cited Date: 2025-02-07 Product: Journal: Folia Medica Cited Date: 2021-03-11 Product: Journal: Avicenna Journal of Medical Biochemistry Author: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Dhaka, Dhaka-1000, Bangladesh Sample: plasma Cited Date: 2025-02-14 Product: Journal: Science Letters Author: Collaborative Drug Discovery Research (CDDR) Group, Faculty of Pharmacy, Universiti Teknologi MARA (UiTM) Cawangan Selangor, Kampus Puncak Alam, 42300 Bandar Puncak Alam, Selangor Darul Ehsan, Malaysia Cited Date: 2023-07-07 Product: Whats the plate size in FineTest ELISA Kits
Mounjaro introduced tirzepatide as a dual GIP/GLP-1 receptor agonist for type 2 diabetes
Characterization of the human PANK2 promoter
That's the point at which regulators assess whether the product should have market authorisation based on the evidence package submitted